Biosysen Limited
1355.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$203.28M
Close$
$-0.03
112.5% downside
Current Fair Value
112.5% downsideOvervalued by 112.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $203.28 Million |
|---|---|
| Enterprise Value | $304.10 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.05 |
| Beta | -0.1 |
| Outstanding Shares | 1,449,673,265 |
Return
| Return on Equity | 324.72% |
|---|---|
| Return on Assets | -65.33% |
| Return on Invested Capital | 299.06% |
Valuation & Multiples
| P/E Ratio | -15 |
|---|---|
| PEG | 5.84 |
| Price to Sales | - |
| Price to Book Ratio | -0.21 |
| Enterprise Value to Revenue | 3.1 |
| Enterprise Value to EBIT | -6.94 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.34 |
| Debt to Equity | -7.08 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Biosysen Limited
94 employees
CEO: Mei Zhonghua Legend Strategy International Holdings Group Company Limited, an investment holding company, engages in the accommodation operation and consultancy business in the People’s Republic of China. It also provides property facilities manageme...